Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus

Epstein-Barr virus, a member of the Herpesviridae family, is responsible for the infectious mononucleosis clinical syndrome, which mainly includes the pharyngitis, fever, and lymphadenopathy triad after incubation for 30-50 days. The liver is involved in 80-90% of patients in a self-limiting transie...

Full description

Bibliographic Details
Authors: Ontanilla-Clavijo, Guillermo; Praena Segovia, Julia; Giráldez Gallego, Álvaro; Cordero Matia, María Elisa; Sousa Martín, José Manuel
Format: Article
Status:Published version
Publication date:2017
Country:España
Institution:Universidad de Sevilla (US)
Repository:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/158771
Online Access:https://hdl.handle.net/11441/158771
https://doi.org/10.17235/reed.2017.4072/2015
Access Level:Open access
Keyword:Epstein-Barr virus
Acute hepatitis
Hemolytic anemia
_version_ 1878732261758599168
author Ontanilla-Clavijo, Guillermo
author2 Praena Segovia, Julia
Giráldez Gallego, Álvaro
Cordero Matia, María Elisa
Sousa Martín, José Manuel
author2_role author
author
author
author
author_browse Cordero Matia, María Elisa
Giráldez Gallego, Álvaro
Ontanilla-Clavijo, Guillermo
Praena Segovia, Julia
Sousa Martín, José Manuel
author_facet Ontanilla-Clavijo, Guillermo
Praena Segovia, Julia
Giráldez Gallego, Álvaro
Cordero Matia, María Elisa
Sousa Martín, José Manuel
author_role author
collection idUS. Depósito de Investigación de la Universidad de Sevilla
description Epstein-Barr virus, a member of the Herpesviridae family, is responsible for the infectious mononucleosis clinical syndrome, which mainly includes the pharyngitis, fever, and lymphadenopathy triad after incubation for 30-50 days. The liver is involved in 80-90% of patients in a self-limiting transient manner, with jaundice being much more uncommon (5%). From a hematological standpoint it may manifest aplastic anemia, neutropenia, and thrombocytopenia. We report a case of infectious mononucleosis that included severe acute hepatitis and was associated with severe hemolytic anemia secondary to cold agglutinins. After exclusion of other etiologies, and given the clinical suspicion of the above association, which was later confirmed by lab tests, empiric therapy was initiated with antiviral agents (aciclovir + valganciclovir) and corticoids, which resulted in a progressive clinical improvement until complete remission. Therefore, we believe that this case report will reinforce the clinical evidence in support of the above combined therapy for serious infectious mononucleosis as a step prior to liver transplantation.
eu_rights_str_mv openAccess
format article
id ES_3f9fd1ddbc44ff2e56fbc1bcb28e861d
institution Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:idus.us.es:11441/158771
publishDate 2017
publishDateSort 2017
publisher Aran Ediciones S.A.
publisherStr Aran Ediciones S.A.
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
spelling Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus Ontanilla-Clavijo, Guillermo Praena Segovia, Julia Giráldez Gallego, Álvaro Cordero Matia, María Elisa Sousa Martín, José Manuel Epstein-Barr virus Acute hepatitis Hemolytic anemia Epstein-Barr virus, a member of the Herpesviridae family, is responsible for the infectious mononucleosis clinical syndrome, which mainly includes the pharyngitis, fever, and lymphadenopathy triad after incubation for 30-50 days. The liver is involved in 80-90% of patients in a self-limiting transient manner, with jaundice being much more uncommon (5%). From a hematological standpoint it may manifest aplastic anemia, neutropenia, and thrombocytopenia. We report a case of infectious mononucleosis that included severe acute hepatitis and was associated with severe hemolytic anemia secondary to cold agglutinins. After exclusion of other etiologies, and given the clinical suspicion of the above association, which was later confirmed by lab tests, empiric therapy was initiated with antiviral agents (aciclovir + valganciclovir) and corticoids, which resulted in a progressive clinical improvement until complete remission. Therefore, we believe that this case report will reinforce the clinical evidence in support of the above combined therapy for serious infectious mononucleosis as a step prior to liver transplantation. Aran Ediciones S.A. https://hdl.handle.net/11441/158771 https://doi.org/10.17235/reed.2017.4072/2015
spellingShingle Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
Ontanilla-Clavijo, Guillermo
Epstein-Barr virus
Acute hepatitis
Hemolytic anemia
status_str publishedVersion
title Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
title_full Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
title_fullStr Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
title_full_unstemmed Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
title_short Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
title_sort Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus
topic Epstein-Barr virus
Acute hepatitis
Hemolytic anemia
topic_facet Epstein-Barr virus
Acute hepatitis
Hemolytic anemia
url https://hdl.handle.net/11441/158771
https://doi.org/10.17235/reed.2017.4072/2015